These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6165673)

  • 1. Experimental allergic encephalomyelitis--susceptibility and suppression.
    Arnon R
    Immunol Rev; 1981; 55():5-30. PubMed ID: 6165673
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis.
    Mokhtarian F; Shirazian T; Batuman O; Shi Y
    Ann N Y Acad Sci; 1996 Feb; 778():414-7. PubMed ID: 8611007
    [No Abstract]   [Full Text] [Related]  

  • 3. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids.
    Webb C; Teitelbaum D; Herz A; Arnon R; Sela M
    Immunochemistry; 1976 Apr; 13(4):333-7. PubMed ID: 59690
    [No Abstract]   [Full Text] [Related]  

  • 5. Subtle effects on myelin basic protein-specific T cell responses can lead to a major reduction in disease susceptibility in experimental allergic encephalomyelitis.
    Vowles C; Chan VS; Bodmer HC
    J Immunol; 2000 Jul; 165(1):75-82. PubMed ID: 10861037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
    Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9470-4. PubMed ID: 2480602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis: prevention with a nontoxic derivative of a cobra neurotoxin.
    Hudson RA; Montgomery IN; Rauch HC
    Mol Immunol; 1983 Feb; 20(2):229-32. PubMed ID: 6188951
    [No Abstract]   [Full Text] [Related]  

  • 9. Myelin basic protein.
    Day ED
    Contemp Top Mol Immunol; 1981; 8():1-39. PubMed ID: 6166428
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques.
    Slierendregt BL; Hall M; 't Hart B; Otting N; Anholts J; Verduin W; Claas F; Jonker M; Lanchbury JS; Bontrop RE
    Int Immunol; 1995 Oct; 7(10):1671-9. PubMed ID: 8562513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental allergic encephalomyelitis.
    Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
    Nature; 1972 Dec; 240(5383):564-6. PubMed ID: 4119624
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis.
    Lisak RP; Zweiman B
    Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110
    [No Abstract]   [Full Text] [Related]  

  • 13. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
    Zhou SR; Whitaker JN
    J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune encephalomyelitis in mice: Lyt and Ia phenotypes of the effector and suppressor cells.
    Bernard CC; Mackay IR
    Prog Clin Biol Res; 1984; 146():277-84. PubMed ID: 6232623
    [No Abstract]   [Full Text] [Related]  

  • 15. Species-specificity and localization of encephalitogenic sites in myelin basic protein.
    Kies MW
    Springer Semin Immunopathol; 1985; 8(3):295-303. PubMed ID: 2413562
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
    Miller A; Lider O; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-encephalitogenic synthetic analogues of the determinant for allergic encephalomyelitis in guinea pigs.
    Hashim GA; Sharpe RD
    Nature; 1975 Jun; 255(5508):484-5. PubMed ID: 49022
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-encephalitogenic antigen-induced suppression and reversal of allergic encephalomyelitis.
    Hashim GA
    Nature; 1975 Aug; 256(5518):953-5. PubMed ID: 52118
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A suppressor cell line that prevents the adoptive transfer of EAE in Lewis rats.
    Ellerman K; Brostoff S
    Ann N Y Acad Sci; 1988; 540():364-6. PubMed ID: 2462813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.